Botulinum toxin type A for spastic cerebral palsy: Is it time to change praxis?

J Rehabil Med. 2020 Feb 7;52(2):jrm00014. doi: 10.2340/16501977-2641.

Authors

Hristina Colovic¹, Lidija Dimitrijevic, Ivona Stankovic, Dragana Radovic-Janosevic, Dragan Zlatanovic

Affiliation

¹ Department for physical medicine and rehabilitation, Facuty of Medicine, University of Nis, , 18000 Nis, Serbia. hristina.colovic@medfak.ni.ac.rs.

PMID: 31922204
DOI: 10.2340/16501977-2641

Abstract

Missing (Letter).

Publication types

Letter

MeSH terms

Botulinum Toxins, Type A / pharmacology
Botulinum Toxins, Type A / therapeutic use*
Cerebral Palsy / drug therapy*
Female
Humans
Male
Muscle Spasticity / drug therapy*
Neuromuscular Agents / pharmacology
Neuromuscular Agents / therapeutic use*
Treatment Outcome

Substances

Neuromuscular Agents
Botulinum Toxins, Type A